Understanding the practical and clinical differences helps patients and providers make informed treatment decisions
Aqueous synthesis: This emerging alternative to SPPS uses water and biologics (like enzymes) to build peptides, eliminating the need for hazardous solvents and reagents
Hospitals adoption of GLP-1 receptor agonists is driven by their ability to manage and treat diabetic patients with a variety of therapeutic options, from daily injections to newly available oral formulations
Isolation and partial characterization of the two major subunits of the BF1 factor (ATPase) from Micrococcus lysodeikticus and evidence for their glycoprotein nature
NAD+ research is one of the most active areas in longevity science
By accessing this website and placing an order, you confirm that you are a qualified researcher, laboratory professional, or authorised representative acting on behalf of a research institution, and that all products purchased will be handled in accordance with applicable regulations and standard laboratory safety practices.